Progenics Pharma Stock Price (NASDAQ:PGNX)

Add to My Stocks
$6.59 $0 (0%) PGNX stock closing price Jul 21, 2017 (Closing)
Prev Close* : $6.59
Market Cap:
Day Low: $6.52
52 Week Low: $4.84
Open: $6.65
Volume: 512456
Day High: $6.66
52 Week High: $11.72

Latest Stock Market News

Latest Articles

Progenics Pharma News - From Partners

PGNX Stockcharts

View PGNX PE ratio, PS ratio stocks charts and compare with peers.
PGNX Chart
Note: Compare Progenics Pharma stock price history with the index and industry peers.

Progenics Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Progenics Pharma Returns

(return on equity)

Progenics Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

PGNX Industry Peers

Company Price Change (%)
Versartis (VSAR)18.250.6 (3.4%)
Axogen (AXGN)16.950.1 (0.59%)
Nektar Therapeutics (NKTR)22.240.07 (0.32%)
Sucampo Pharma (SCMP)10.950.05 (0.46%)
Cytodyn (CYDY)0.730.02 (2.82%)
Valeant Pharmaceuticals Intl Inc (VRX)17.50.1 (0.57%)
Johnson & Johnson (JNJ)135.311.26 (0.92%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Versartis (VSAR)18.250.6 (3.4%)
Mallinckrodt (MNK)47.420.71 (1.52%)
Impax Lab (IPXL)18.150.2 (1.11%)
Allergan (AGN)250.971.9 (0.76%)
Teva Pharmaceutical (TEVA)32.640.21 (0.65%)
AxoGen (AXGN)16.950.1 (0.59%)
Dr. Reddy's Laboratories (RDY)42.460.23 (0.54%)
Top gainers from Medical-Generic Drugs industry
* As of Jul 22, 2017
CompanyPriceChange (%)
Agile Therapeutics (AGRX)5.190.18 (3.35%)
Corium (CORI)8.870.16 (1.77%)
Mylan (MYL)39.170.32 (0.81%)
Teligent (TLGT)8.4350.06 (0.71%)
Supernus Pharma (SUPN)42.20.1 (0.24%)
Akorn (AKRX)33.60.05 (0.15%)
Aquinox Pharma (AQXP)14.890.01 (0.07%)
Top losers from Medical-Generic Drugs industry
* As of Jul 22, 2017

Progenics Pharmaceuticals, Inc. Stock News - Partner Headlines

Progenics Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues69.42M8.67M44.37M7.86M14.04M
Net Income10.8M-39.11M4.41M-42.57M-35.43M
Total Operating Expense56.31M47.97M41M50.82M49.52M
view Progenics Pharmaceuticals, Inc. income statement
balance sheet20162015201420132012
Total Assets198.98M131.25M161.03M114.54M76.3M
Total Liabilities94.22M40.59M36.12M35.56M9.74M
Shareholders Equity104.76M90.66M124.9M78.97M66.56M
view Progenics Pharmaceuticals, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities6.22M-5.99M2.25M1.41M-6.74M
Net Cash From (Used By) Operating Activities19.2M-40.13M13.72M-36.1M-34.64M
Increase (Decrease) In Prop Plant And Equipment-3.93M-0.32M-0.57M0.03M-0.37M
view Progenics Pharmaceuticals, Inc. cashflow statement

Progenics Pharma Stock Message Board

An investor needs to spend 6.59 to buy PGNX stock, as the closing Progenics Pharma stock price is 6.59. Looking at Progenics Pharma market capitalization, which currently stands at 462.78M, we can say that PGNX stock is a Small cap stock. Progenics Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Progenics Pharma is worth a lot, it will most likely be reflected in an inflated Progenics Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in Progenics Pharma stock quote data shows the number of shares traded. For Ex: 512456 Progenics Pharma shares were traded as of last trading day, as seen from Progenics Pharma stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Progenics Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.